CDRI-S002-333

N/A

Report date: 2025/06/11 11:15:56
NME

Base Information

Drug NameCDRI-S002-333
Drug Alias Nameantithrombotic compounds (CDRI/Cosmic Discoveries)S-000-20S-001-556CDRI-S002-333S-002-333 +[6] 
ClassificationSmall molecules
Mechanisms of ActionCoagulation factor inhibitorsPlatelet aggregation inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentral Drug Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesCosmic DiscoveriesCentral Drug Research Institute
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A